ReShape Lifesciences Inc. (NASDAQ:RSLS) Short Interest Up 40.4% in January

ReShape Lifesciences Inc. (NASDAQ:RSLS) was the recipient of a large increase in short interest in January. As of January 31st, there was short interest totalling 22,600 shares, an increase of 40.4% from the January 15th total of 16,100 shares. Approximately 3.3% of the company’s stock are short sold. Based on an average trading volume of 59,800 shares, the days-to-cover ratio is presently 0.4 days.

ReShape Lifesciences Stock Performance

Shares of NASDAQ RSLS traded down $0.21 during trading on Friday, hitting $2.33. The stock had a trading volume of 123,469 shares, compared to its average volume of 47,470. ReShape Lifesciences has a 12 month low of $2.32 and a 12 month high of $29.00. The firm has a fifty day moving average of $4.21 and a two-hundred day moving average of $6.17.

About ReShape Lifesciences

ReShape Lifesciences Inc provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. The company's product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy; Lap-Band 2.0 System, an adjustable postoperatively to increase or decrease the pressure to the band in order to optimize an individual's comfort and therapy effectiveness; and ReShape Calibration Tubes, that fits the lesser curvature of the stomach to reach the pylorus.